No evidence for higher risk of cancer in patients with multiple sclerosis taking cladribine.
Författare
Summary, in English
To compare the cancer risk of cladribine and other disease-modifying drugs (DMDs) in trials of people with relapsing multiple sclerosis (pwRMS).
Avdelning/ar
- Stamcellscentrum (SCC)
- BioCARE: Biomarkers in Cancer Medicine improving Health Care, Education and Innovation
Publiceringsår
2015
Språk
Engelska
Publikation/Tidskrift/Serie
Neurology: Neuroimmunology and NeuroInflammation
Volym
2
Issue
6
Fulltext
- Available as PDF - 670 kB
- Download statistics
Länkar
Dokumenttyp
Artikel i tidskrift
Förlag
Lippincott Williams & Wilkins
Ämne
- Neurology
Status
Published
ISBN/ISSN/Övrigt
- ISSN: 2332-7812